How has been the historical performance of DRS Dilip Road?

Nov 15 2025 12:22 AM IST
share
Share Via
DRS Dilip Road's financial performance from March 2022 to March 2023 showed increased net sales and operating income, but a decline in profit after tax and earnings per share. Total liabilities and assets rose, while cash flow from operating activities improved, but net cash flow turned negative.
Answer:
The historical performance of DRS Dilip Road shows a mixed trend in financial metrics from March 2022 to March 2023. Breakdown: In the fiscal year ending March 2023, DRS Dilip Road reported net sales of 205.58 crore, an increase from 190.90 crore in the previous year. Total operating income also rose to 205.58 crore from 190.90 crore. The company's total expenditure, excluding depreciation, increased to 194.97 crore from 181.50 crore, driven by higher employee costs and other expenses. Operating profit (PBDIT) improved to 11.97 crore from 11.48 crore, while profit before tax decreased to 5.78 crore from 6.61 crore. Consequently, profit after tax fell to 4.19 crore from 4.63 crore, leading to a decline in earnings per share from 3.07 to 2.78. On the balance sheet, total liabilities increased to 115.31 crore from 97.61 crore, with total debt slightly rising to 18.28 crore. Shareholder's funds grew to 56.23 crore from 52.04 crore, and total assets increased to 115.31 crore from 97.61 crore. Cash flow from operating activities improved to 12.00 crore from 9.00 crore, but the net cash outflow was 3.00 crore compared to an inflow of 4.00 crore in the previous year.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is DRS Dilip Roadlines Ltd falling/rising?
Dec 25 2025 02:12 AM IST
share
Share Via
Is DRS Dilip Road overvalued or undervalued?
Nov 28 2025 08:22 AM IST
share
Share Via
Is DRS Dilip Road overvalued or undervalued?
Nov 20 2025 08:08 AM IST
share
Share Via
Is DRS Dilip Road overvalued or undervalued?
Nov 19 2025 08:12 AM IST
share
Share Via
Is DRS Dilip Road overvalued or undervalued?
Nov 09 2025 08:12 AM IST
share
Share Via
Is DRS Dilip Road overvalued or undervalued?
Nov 08 2025 08:12 AM IST
share
Share Via
Is DRS Dilip Road overvalued or undervalued?
Nov 07 2025 08:14 AM IST
share
Share Via
Most Read
Saboo Sodium Chloro Ltd is Rated Sell
51 minutes ago
share
Share Via
Jenburkt Pharmaceuticals Ltd. is Rated Sell
51 minutes ago
share
Share Via
iStreet Network Ltd is Rated Sell
51 minutes ago
share
Share Via
Emmbi Industries Ltd is Rated Sell
51 minutes ago
share
Share Via
Cohance Lifesciences Ltd is Rated Sell
51 minutes ago
share
Share Via
Vivo Bio Tech Ltd. is Rated Strong Sell
51 minutes ago
share
Share Via